Paul Peter Tak Candel Therapeutics, Inc. (CADL) insider trading activity
Paul Peter Tak is Chief Executive Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 225,740 shares of CADL, which is worth approximately $1.34 Million. The most recent transaction as insider was on Mar 19, 2025, when has been sold 400 shares (Common Stock) at a price of $9.0 per share, resulting in proceeds of $3,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
226K
23.42%
3M change
39.57%
12M change
Total Value Held
$1.34 Million
Paul Peter Tak Transaction History
PPT
Paul Peter Tak
Chief Executive Officer
Needham, MA